Uncovering a New Moral Dilemma of Economic Optimization in Biotechnological Processing
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28597218
DOI
10.1007/s11948-017-9925-z
PII: 10.1007/s11948-017-9925-z
Knihovny.cz E-zdroje
- Klíčová slova
- Bioeconomy, Financial optimization, Logistics, Moral dilemma, Public health costs,
- MeSH
- alergie etiologie MeSH
- analýza nákladů a výnosů MeSH
- biomasa MeSH
- biopaliva * MeSH
- biotechnologie MeSH
- etika podnikání MeSH
- lidé MeSH
- mravy MeSH
- poskytování zdravotní péče ekonomika MeSH
- průmysl ekonomika etika MeSH
- průmyslová hnojiva * MeSH
- pyl škodlivé účinky MeSH
- rostliny * MeSH
- sociální odpovědnost MeSH
- technologie * MeSH
- vystavení vlivu životního prostředí škodlivé účinky etika MeSH
- zemědělství ekonomika etika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- biopaliva * MeSH
- průmyslová hnojiva * MeSH
The trend of emerging biorefineries is to process the harvest as efficiently as possible and without any waste. From the most valuable phytomass, refined medicines, enzymes, dyes and other special reactants are created. Functional foods, food ingredients, oils, alcohol, solvents, plastics, fillers and a wide variety of other chemical products follow. After being treated with nutrient recovery techniques (for fertilizer production), biofuels or soil improvers are produced from the leftovers. Economic optimization algorithms have confirmed that such complex biorefineries can be financially viable only when a high degree of feedstock concentration is included. Because the plant material is extremely voluminous before processing, the farming intensity of special plants increases in the nearest vicinity of agglomerations where the biorefineries are built for logistical reasons. Interdisciplinary analyses revealed that these optimization measures lead to significantly increased pollen levels in neighbouring urban areas and subsequently an increased risk of allergies, respectively costs to the national health system. A new moral dilemma between the shareholder's profit and public interest was uncovered and subjected to disputation.
Zobrazit více v PubMed
Allergy. 2012 Aug;67(8):1083 PubMed
Bioresour Technol. 2010 Dec;101(23):8915-22 PubMed
Int J Oncol. 2010 May;36(5):1053-60 PubMed
J Appl Phycol. 2016;28(6):3511-3525 PubMed
Appl Microbiol Biotechnol. 2004 Apr;64(2):137-45 PubMed
Org Biomol Chem. 2003 May 21;1(10):1684-9 PubMed
Contact Dermatitis. 1998 Mar;38(3):123-6 PubMed
Environ Sci Pollut Res Int. 2014 Jun;21(12):7400-2 PubMed
Curr Opin Environ Sustain. 2010 Dec;2(5-6):394-403 PubMed
Environ Sci Pollut Res Int. 2014 May;21(9):6218-20 PubMed
Science. 2014 May 16;344(6185):1246843 PubMed
Sci Eng Ethics. 2016 Apr;22(2):581-90 PubMed
Allergy. 2007 Sep;62(9):976-90 PubMed
J Biol Regul Homeost Agents. 2006 Jul-Dec;20(3-4):47-52 PubMed
J Biotechnol. 2010 Oct 1;150(1):51-6 PubMed
